Journal
EMERGING INFECTIOUS DISEASES
Volume 26, Issue 12, Pages 2970-2973Publisher
CENTERS DISEASE CONTROL & PREVENTION
DOI: 10.3201/eid2612.203309
Keywords
-
Categories
Funding
- Wellcome Trust
- National Institute for Health Research Birmingham Biomedical Research Centre at the University Hospitals Birmingham NHS Foundation Trust
- University of Birmingham
- Saving Lives Charity (UK Charity Commission) [1144855]
- International AIDS Vaccine Initiative
- Bill and Melinda Gates Foundation through the Collaboration for AIDS Vaccine Discovery [OPP1196345/INV-008813, OPP1084519, OPP1115782]
- Scripps Consortium for HIV Vaccine Development (National Institutes of Health National Institute for Allergy and Infectious Diseases grant) [AI144462]
- University of Southampton Coronavirus Response Fund
- MRC [MC_PC_17183] Funding Source: UKRI
Ask authors/readers for more resources
Dried blood spot (DBS) samples can be used for the detection of severe acute respiratory syndrome corona virus 2 spike antibodies. DBS sampling is comparable to matched serum samples with a relative 98.1% sensitivity and 100% specificity. Thus, DBS sampling offers an alternative for population-wide serologic testing ill the coronavirus pandemic.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
